Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-05
DOI
10.1038/s41416-020-1017-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Osteosarcoma‐initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B
- (2019) Emi Mizushima et al. CANCER SCIENCE
- Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
- (2017) Christiane R Stadler et al. NATURE MEDICINE
- The future of immunotherapy for sarcoma
- (2016) Tomohide Tsukahara et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Peptide vaccination therapy: Towards the next generation
- (2016) Tomohide Tsukahara et al. PATHOLOGY INTERNATIONAL
- Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance
- (2016) Kenji Murata et al. OncoImmunology
- Immune responses to human cancer stem-like cells/cancer-initiating cells
- (2015) Yoshihiko Hirohashi et al. CANCER SCIENCE
- Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer
- (2015) Julia Stieglmaier et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
- (2015) Tao Dao et al. NATURE BIOTECHNOLOGY
- Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells
- (2014) Rena Morita et al. CANCER SCIENCE
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Specific Targeting of a Naturally Presented Osteosarcoma Antigen, Papillomavirus Binding Factor Peptide, Using an Artificial Monoclonal Antibody
- (2014) Tomohide Tsukahara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem-like Cells
- (2012) S. Nishizawa et al. CANCER RESEARCH
- Antibody-Based Immunotherapy of Cancer
- (2012) Louis M. Weiner et al. CELL
- Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
- (2011) Berna Bozkurt Duman et al. MEDICAL ONCOLOGY
- Parallel kinetic analysis and affinity determination of hundreds of monoclonal antibodies using the ProteOn XPR36
- (2008) Oded Nahshol et al. ANALYTICAL BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation